Individualized therapy is a long-term cost-effective method compared to dose intensification in Crohn's disease patients failing infliximab

C Steenholdt, J Brynskov, OØ Thomsen… - Digestive diseases and …, 2015 - Springer
Abstract Background In Crohn's disease patients failing infliximab therapy, interventions
defined by an algorithm based on infliximab and anti-infliximab antibody measurements …
被引用次数：92 相关文章

Individualized Therapy Is a Long-Term Cost-Effective Method Compared to Dose Intensification in Crohn's Disease Patients Failing Infliximab

C Steenholdt, J Brynskov, OØ Thomsen… - Digestive Diseases and …, 2015 - pure.au.dk
BACKGROUND: In Crohn's disease patients failing infliximab therapy, interventions defined
by an algorithm based on infliximab and anti-infliximab antibody measurements have …

Individualized Therapy Is a Long-Term Cost-Effective Method Compared to Dose Intensification in Crohn's Disease Patients Failing Infliximab

C Steenholdt, J Brynskov, OØ Thomsen… - Digestive Diseases and …, 2015 - infona.pl
Background In Crohn's disease patients failing infliximab therapy, interventions defined by
an algorithm based on infliximab and anti-infliximab antibody measurements have proven …
[PDF] academia.edu

[PDF][PDF] Individualized Therapy Is a Long-Term Cost-Effective Method Compared to Dose Intensification in Crohn's Disease Patients Failing Infliximab

C Steenholdt, J Brynskov, OØ Thomsen, LK Munck… - 2015 - academia.edu
Abstract Background In Crohn's disease patients failing infliximab therapy, interventions
defined by an algorithm based on infliximab and anti-infliximab antibody measurements …

Individualized Therapy Is a Long-Term Cost-Effective Method Compared to Dose Intensification in Crohn's Disease Patients Failing Infliximab

C Steenholdt, J Brynskov, OØ Thomsen… - Digestive Diseases …, 2015 - research.regionh.dk
BACKGROUND: In Crohn's disease patients failing infliximab therapy, interventions defined
by an algorithm based on infliximab and anti-infliximab antibody measurements have …

[引用][C] Individualized Therapy Is a Long-Term Cost-Effective Method Compared to Dose Intensification in Crohn's Disease Patients Failing Infliximab

C Steenholdt, J Brynskov, OØ Thomsen… - Digestive Diseases and …, 2015 - cir.nii.ac.jp
Individualized Therapy Is a Long-Term Cost-Effective Method Compared to Dose Intensification
in Crohn’s Disease Patients Failing Infliximab | CiNii Research CiNii 国立情報学研究所 学術 …

Individualized Therapy Is a Long-Term Cost-Effective Method Compared to Dose Intensification in Crohn's Disease Patients Failing Infliximab

C Steenholdt, J Brynskov, OØ Thomsen… - Digestive Diseases and …, 2015 - vbn.aau.dk
BACKGROUND: In Crohn's disease patients failing infliximab therapy, interventions defined
by an algorithm based on infliximab and anti-infliximab antibody measurements have …

Individualized Therapy Is a Long-Term Cost-Effective Method Compared to Dose Intensification in Crohn's Disease Patients Failing Infliximab.

C Steenholdt, J Brynskov, OØ Thomsen… - Digestive Diseases …, 2015 - europepmc.org
Background In Crohn's disease patients failing infliximab therapy, interventions defined by
an algorithm based on infliximab and anti-infliximab antibody measurements have proven …

Individualized Therapy Is a Long-Term Cost-Effective Method Compared to Dose Intensification in Crohn's Disease Patients Failing Infliximab.

C Steenholdt, J Brynskov, O Thomsen… - Digestive Diseases …, 2015 - search.ebscohost.com
Abstract Background: In Crohn's disease patients failing infliximab therapy, interventions
defined by an algorithm based on infliximab and anti-infliximab antibody measurements …

Individualized Therapy Is a Long-Term Cost-Effective Method Compared to Dose Intensification in Crohn's Disease Patients Failing Infliximab

C Steenholdt, J Brynskov, OØ Thomsen… - Digestive Diseases …, 2015 - search.proquest.com
Background In Crohn's disease patients failing infliximab therapy, interventions defined by
an algorithm based on infliximab and anti-infliximab antibody measurements have proven …